192 related articles for article (PubMed ID: 31729903)
1. The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension.
Younes ST; Maeda KJ; Sasser J; Ryan MJ
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H72-H77. PubMed ID: 31729903
[TBL] [Abstract][Full Text] [Related]
2. Carbon Monoxide Releasing Molecules Blunt Placental Ischemia-Induced Hypertension.
George EM; Cockrell K; Arany M; Stec DE; Rimoldi JM; Gadepalli RSV; Granger JP
Am J Hypertens; 2017 Sep; 30(9):931-937. PubMed ID: 28472389
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil attenuates placental ischemia-induced hypertension.
George EM; Palei AC; Dent EA; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R397-403. PubMed ID: 23785075
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide Improves Renal Endothelial Function in Obese Zucker Rats on a High-Salt Diet.
Sukumaran V; Tsuchimochi H; Sonobe T; Shirai M; Pearson JT
J Pharmacol Exp Ther; 2019 Jun; 369(3):375-388. PubMed ID: 30910920
[TBL] [Abstract][Full Text] [Related]
5. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
[TBL] [Abstract][Full Text] [Related]
7. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
[TBL] [Abstract][Full Text] [Related]
8. Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.
Santiago-Font JA; Amaral LM; Faulkner J; Ibrahim T; Vaka VR; Cunningham MW; LaMarca B
Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1158-R1163. PubMed ID: 27629886
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I
Thromb Haemost; 2017 Jun; 117(6):1115-1128. PubMed ID: 28405672
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor action in the vasculature.
Almutairi M; Al Batran R; Ussher JR
Peptides; 2019 Jan; 111():26-32. PubMed ID: 30227157
[TBL] [Abstract][Full Text] [Related]
11. The GLP-1 receptor agonist liraglutide protects against oxidized LDL-induced endothelial inflammation and dysfunction via KLF2.
Yue W; Li Y; Ou D; Yang Q
IUBMB Life; 2019 Sep; 71(9):1347-1354. PubMed ID: 30969479
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways.
Le Y; Wei R; Yang K; Lang S; Gu L; Liu J; Hong T; Yang J
Peptides; 2020 Feb; 124():170212. PubMed ID: 31770577
[TBL] [Abstract][Full Text] [Related]
13. Empagliflozin, alone or in combination with liraglutide, limits cell death in vitro: role of oxidative stress and nitric oxide.
Cessario J; Pierre-Louis V; Wahl J; Li Z
Pharmacol Rep; 2021 Jun; 73(3):858-867. PubMed ID: 33555600
[TBL] [Abstract][Full Text] [Related]
14. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells.
Hattori Y; Jojima T; Tomizawa A; Satoh H; Hattori S; Kasai K; Hayashi T
Diabetologia; 2010 Oct; 53(10):2256-63. PubMed ID: 20593161
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway.
Ke J; Liu Y; Yang J; Lu R; Tian Q; Hou W; Wang G; Wei R; Hong T
Sci Rep; 2017 Feb; 7():41085. PubMed ID: 28145471
[TBL] [Abstract][Full Text] [Related]
18. GLP-1R Agonist Liraglutide Attenuates Inflammatory Reaction and Neuronal Apoptosis and Reduces Early Brain Injury After Subarachnoid Hemorrhage in Rats.
Tu XK; Chen Q; Chen S; Huang B; Ren BG; Shi SS
Inflammation; 2021 Feb; 44(1):397-406. PubMed ID: 32951103
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide].
Haluzík M; Trachta P; Mráz M
Vnitr Lek; 2015; 61(7-8):635-40. PubMed ID: 26375689
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide Accelerates Ischemia-Induced Angiogenesis in a Murine Diabetic Model.
Zhu YX; Li Y; Ma Y; Zhang X; Du X; Gao J; Ding NH; Wang L; Chen N; Luo M; Wu J; Li R
J Am Heart Assoc; 2023 Feb; 12(4):e026586. PubMed ID: 36789853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
